Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Gagan Joshi, M.D.

Co-Author

This page shows the publications co-authored by Gagan Joshi and Janet Wozniak.
Connection Strength

4.014
  1. Examining the comorbidity of bipolar disorder and autism spectrum disorders: a large controlled analysis of phenotypic and familial correlates in a referred population of youth with bipolar I disorder with and without autism spectrum disorders. J Clin Psychiatry. 2013 Jun; 74(6):578-86.
    View in: PubMed
    Score: 0.577
  2. A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder. World J Biol Psychiatry. 2020 04; 21(4):274-290.
    View in: PubMed
    Score: 0.227
  3. Predictive utility of autistic traits in youth with ADHD: a controlled 10-year longitudinal follow-up study. Eur Child Adolesc Psychiatry. 2020 Jun; 29(6):791-801.
    View in: PubMed
    Score: 0.222
  4. A Retrospective Chart Review of Buspirone for the Treatment of Anxiety in Psychiatrically Referred Youth with High-Functioning Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2019 02; 29(1):28-33.
    View in: PubMed
    Score: 0.211
  5. High Risk for Severe Emotional Dysregulation in Psychiatrically Referred Youth with Autism Spectrum Disorder: A Controlled Study. J Autism Dev Disord. 2018 Sep; 48(9):3101-3115.
    View in: PubMed
    Score: 0.207
  6. Further evidence of high level of persistence of pediatric bipolar-I disorder from childhood onto young adulthood: a five-year follow up. Scand J Child Adolesc Psychiatr Psychol. 2018; 6(1):40-51.
    View in: PubMed
    Score: 0.205
  7. Prescribing Patterns in a Psychiatrically Referred Sample of Youth With Autism Spectrum Disorder. J Clin Psychiatry. 2017 Nov/Dec; 78(9):e1276-e1283.
    View in: PubMed
    Score: 0.196
  8. A Prospective Open-Label Trial of Memantine Hydrochloride for the Treatment of Social Deficits in Intellectually Capable Adults With Autism Spectrum Disorder. J Clin Psychopharmacol. 2016 Jun; 36(3):262-71.
    View in: PubMed
    Score: 0.178
  9. Examining the clinical correlates of autism spectrum disorder in youth by ascertainment source. J Autism Dev Disord. 2014 Sep; 44(9):2117-26.
    View in: PubMed
    Score: 0.157
  10. Symptom Profile of ADHD in Youth With High-Functioning Autism Spectrum Disorder: A Comparative Study in Psychiatrically Referred Populations. J Atten Disord. 2017 Aug; 21(10):846-855.
    View in: PubMed
    Score: 0.156
  11. Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: a comparative study. J Autism Dev Disord. 2013 Jun; 43(6):1314-25.
    View in: PubMed
    Score: 0.144
  12. A prospective open-label trial of paliperidone monotherapy for the treatment of bipolar spectrum disorders in children and adolescents. Psychopharmacology (Berl). 2013 Jun; 227(3):449-58.
    View in: PubMed
    Score: 0.141
  13. Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4T. Eur Arch Psychiatry Clin Neurosci. 2013 Aug; 263(5):379-84.
    View in: PubMed
    Score: 0.137
  14. A magnetic resonance spectroscopy study of the anterior cingulate cortex in youth with emotional dysregulation. Isr J Psychiatry Relat Sci. 2012; 49(1):62-9.
    View in: PubMed
    Score: 0.131
  15. Discriminant and concurrent validity of a simplified DSM-based structured diagnostic instrument for the assessment of autism spectrum disorders in youth and young adults. BMC Psychiatry. 2011 Dec 30; 11:204.
    View in: PubMed
    Score: 0.131
  16. A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder. J Affect Disord. 2012 Feb; 136(3):1143-53.
    View in: PubMed
    Score: 0.129
  17. Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder. CNS Neurosci Ther. 2012 Jan; 18(1):28-33.
    View in: PubMed
    Score: 0.121
  18. The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population. J Autism Dev Disord. 2010 Nov; 40(11):1361-70.
    View in: PubMed
    Score: 0.121
  19. A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neurosci Ther. 2010 Apr; 16(2):91-102.
    View in: PubMed
    Score: 0.116
  20. Clinical characteristics of comorbid obsessive-compulsive disorder and bipolar disorder in children and adolescents. Bipolar Disord. 2010 Mar; 12(2):185-95.
    View in: PubMed
    Score: 0.115
  21. Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder. Bipolar Disord. 2010 Mar; 12(2):196-204.
    View in: PubMed
    Score: 0.115
  22. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. J Child Adolesc Psychopharmacol. 2010 Feb; 20(1):7-14.
    View in: PubMed
    Score: 0.114
  23. An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS Spectr. 2007 Sep; 12(9):683-9.
    View in: PubMed
    Score: 0.097
  24. Can pediatric bipolar-I disorder be diagnosed in the context of posttraumatic stress disorder? A familial risk analysis. Psychiatry Res. 2013 Aug 15; 208(3):215-24.
    View in: PubMed
    Score: 0.036
  25. Child behavior checklist clinical scales discriminate referred youth with autism spectrum disorder: a preliminary study. J Dev Behav Pediatr. 2010 Jul-Aug; 31(6):485-90.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.